Masimirembwa C - Search Results

1

The potential inhibitory effect of antiparasitic drugs and natural products on P-glycoprotein mediated efflux.

Hayeshi R, Masimirembwa C, Mukanganyama S, Ungell AL. Hayeshi R, et al. Among authors: masimirembwa c. Eur J Pharm Sci. 2006 Sep;29(1):70-81. doi: 10.1016/j.ejps.2006.05.009. Epub 2006 Jun 3. Eur J Pharm Sci. 2006. PMID: 16846720

2

Lysosomal trapping of amodiaquine: impact on transport across intestinal epithelia models.

Hayeshi R, Masimirembwa C, Mukanganyama S, Ungell AL. Hayeshi R, et al. Among authors: masimirembwa c. Biopharm Drug Dispos. 2008 Sep;29(6):324-34. doi: 10.1002/bdd.616. Biopharm Drug Dispos. 2008. PMID: 18570280

3

Physicochemical and drug metabolism characterization of a series of 4-aminoquinoline-3-hydroxypyridin-4-one hybrid molecules with antimalarial activity.

Thelingwani R, Bonn B, Chibale K, Masimirembwa C. Thelingwani R, et al. Among authors: masimirembwa c. Expert Opin Drug Metab Toxicol. 2014 Oct;10(10):1313-24. doi: 10.1517/17425255.2014.954547. Expert Opin Drug Metab Toxicol. 2014. PMID: 25219629

4

Influence of CYP3A5*3 and ABCB1 C3435T on clinical outcomes and trough plasma concentrations of imatinib in Nigerians with chronic myeloid leukaemia.

Adeagbo BA, Bolaji OO, Olugbade TA, Durosinmi MA, Bolarinwa RA, Masimirembwa C. Adeagbo BA, et al. Among authors: masimirembwa c. J Clin Pharm Ther. 2016 Oct;41(5):546-51. doi: 10.1111/jcpt.12424. Epub 2016 Jul 18. J Clin Pharm Ther. 2016. PMID: 27426203

5

Characterisation of artemisinin-chloroquinoline hybrids for potential metabolic liabilities.

Thelingwani R, Leandersson C, Bonn B, Smith P, Chibale K, Masimirembwa C. Thelingwani R, et al. Among authors: masimirembwa c. Xenobiotica. 2016;46(3):234-40. doi: 10.3109/00498254.2015.1070975. Epub 2015 Sep 4. Xenobiotica. 2016. PMID: 26338168

6

Evaluation of Herbal Medicines: Value Addition to Traditional Medicines Through Metabolism, Pharmacokinetic and Safety Studies.

Thelingwani R, Masimirembwa C. Thelingwani R, et al. Among authors: masimirembwa c. Curr Drug Metab. 2014;15(10):942-52. doi: 10.2174/1389200216666150206125727. Curr Drug Metab. 2014. PMID: 25658125 Review.

7

Prediction of sites under adaptive evolution in cytochrome P450 sequences and their relationship to substrate recognition sites.

Zawaira A, Matimba A, Masimirembwa C. Zawaira A, et al. Among authors: masimirembwa c. Pharmacogenet Genomics. 2008 Jun;18(6):467-76. doi: 10.1097/FPC.0b013e3282f9b68e. Pharmacogenet Genomics. 2008. PMID: 18496126

8

Extracting molecular information from African natural products to facilitate unique African-led drug-discovery efforts.

Chibale K, Guantai EM, Masimirembwa C. Chibale K, et al. Among authors: masimirembwa c. Future Med Chem. 2011 Mar;3(3):257-61. doi: 10.4155/fmc.10.299. Future Med Chem. 2011. PMID: 21446839 No abstract available.

9

Identification and characterization of reactive metabolites in natural products-driven drug discovery.

Njuguna NM, Masimirembwa C, Chibale K. Njuguna NM, et al. Among authors: masimirembwa c. J Nat Prod. 2012 Mar 23;75(3):507-13. doi: 10.1021/np200786j. Epub 2012 Feb 1. J Nat Prod. 2012. PMID: 22296642 Review.

10

Biotransformation and biocatalysis: roles and applications in the discovery of antimalarials.

Chigorimbo-Murefu NT, Njoroge M, Nzila A, Louw S, Masimirembwa C, Chibale K. Chigorimbo-Murefu NT, et al. Among authors: masimirembwa c. Future Med Chem. 2012 Dec;4(18):2325-36. doi: 10.4155/fmc.12.173. Future Med Chem. 2012. PMID: 23234554 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters